Template:Herpes simplex: Difference between revisions

Jump to navigation Jump to search
Kalsang Dolma (talk | contribs)
No edit summary
Tarek Nafee (talk | contribs)
No edit summary
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Sexually transmitted disease|'''Sexually transmitted diseases Main Page''']]
|-
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 16: Line 23:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex overview|Overview]]
Patient Information
|-  
|-  
!
!
Line 22: Line 29:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Patient Information
:[[Genital herpes (patient information)|Genital Herpes]]
|-  
|-  
!
!
Line 28: Line 35:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Genital herpes (patient information)|Genital herpes]]
:[[Congenital herpes (patient information)|Congenital Herpes]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Congenital herpes (patient information)|Congenital herpes]]
[[Herpes simplex overview|Overview]]
|-  
|-  
!
!
Line 59: Line 65:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex epidemiology and demographics|Epidemiology and Demographics]]
[[Herpes simplex pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 68: Line 73:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex asymptomatic shedding|Asymptomatic Shedding]]
[[Herpes simplex epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 74: Line 79:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex recurrence|Recurrences and Triggers]]
[[Herpes simplex asymptomatic shedding|Asymptomatic Shedding]]
|-  
|-  
!
!
Line 80: Line 85:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Transmission
[[Herpes simplex recurrence|Recurrences and Triggers]]
|-  
|-  
!
!
Line 86: Line 91:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Herpes simplex transmission|Mode of Transmission]]
[[Herpes simplex natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
|- bgcolor="CornFlowerBlue"
|- bgcolor="CornFlowerBlue"
!
!
Line 136: Line 140:
:[[Herpes simplex genitalis antiviral treatment of recurrent genital herpes|Antivirals for Recurrent Genital Herpes]]  
:[[Herpes simplex genitalis antiviral treatment of recurrent genital herpes|Antivirals for Recurrent Genital Herpes]]  


:[[Herpes simplex antiviral therapy#Antiviral treatment for Severe Disease|Antivirals for Severe Disease]]   
:[[Herpes simplex treatment#Topical treatments|Topical Treatments]]
:[[Herpes simplex treatment#Other drugs|Other Drugs]]
:[[Herpes simplex alternative therapies |Alternative Therapies]]
|-  
|-  
!
!
Line 148: Line 145:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Herpes simplex primary prevention|Prevention]]
[[Herpes simplex primary prevention|Primary Prevention]]
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
!
[[Herpes simplex complications|Complications]]
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"

Latest revision as of 16:31, 2 March 2017